Michael Pollak Selected Research

Insulin (Novolin)

1/2023	Obesity promotes breast epithelium DNA damage in women carrying a germline mutation in BRCA1 or BRCA2.
1/2022	Circulating Insulin-Like Growth Factor 1-Related Biomarkers and Risk of Lethal Prostate Cancer.
12/2018	Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease.
11/2017	Long-Term Use of Long-Acting Insulin Analogs and Breast Cancer Incidence in Women With Type 2 Diabetes.
4/2017	Metabolic Obesity, Adipose Inflammation and Elevated Breast Aromatase in Women with Normal Body Mass Index.
1/2016	Influence of Fasting Status and Sample Preparation on Metabolic Biomarker Measurements in Postmenopausal Women.
1/2016	Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer.
8/2014	Circulating IGF-axis protein levels and their relation with levels of plasma adipocytokines and macronutrient consumption in women.
1/2014	Risk of breast cancer by individual insulin use: an international multicenter study.
1/2013	Treatment with insulin analog X10 and IGF-1 increases growth of colon cancer allografts.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Pollak Research Topics

Disease

108	Neoplasms (Cancer) 11/2022 - 07/2002
54	Breast Neoplasms (Breast Cancer) 12/2023 - 03/2002
48	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 07/2002
13	Obesity 01/2023 - 01/2009
13	Carcinogenesis 06/2020 - 07/2005
11	Inflammation (Inflammations) 10/2021 - 04/2007
10	Type 2 Diabetes Mellitus (MODY) 01/2021 - 11/2006
10	Insulin Resistance 02/2020 - 02/2004
10	Hyperinsulinism (Hyperinsulinemia) 08/2012 - 11/2006
9	Pancreatic Neoplasms (Pancreatic Cancer) 11/2022 - 12/2002
8	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 04/2004
6	Colonic Neoplasms (Colon Cancer) 01/2022 - 06/2010
5	Body Weight (Weight, Body) 01/2023 - 12/2007
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2023 - 09/2011
4	Neoplasm Metastasis (Metastasis) 11/2020 - 10/2008
4	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 04/2007
4	Hyperplasia 03/2016 - 02/2004
4	Carcinoma (Carcinomatosis) 03/2016 - 09/2008
3	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 02/2013
3	Leukemia 08/2017 - 08/2011
3	Ovarian Epithelial Carcinoma 11/2011 - 04/2007
2	Kidney Neoplasms (Kidney Cancer) 01/2022 - 12/2018
2	Weight Loss (Weight Reduction) 02/2020 - 01/2017
2	Hepatocellular Carcinoma (Hepatoma) 08/2017 - 04/2012
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2016 - 08/2011
2	Hypertension (High Blood Pressure) 01/2016 - 10/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2014 - 12/2006
2	Disease Progression 09/2014 - 12/2008
2	Diabetes Mellitus 09/2014 - 10/2008

Drug/Important Bio-Agent (IBA)

50	Insulin-Like Growth Factor I (IGF-1)IBA 01/2022 - 07/2002
44	Insulin-Like PeptidesIBA 01/2022 - 11/2002
38	Insulin (Novolin)FDA Link 01/2023 - 12/2002
33	Metformin (Glucophage)FDA LinkGeneric 10/2023 - 11/2006
24	Insulin-Like Growth Factor Binding Protein 3IBA 01/2019 - 07/2002
17	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2004
16	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2005
16	Hormones (Hormone)IBA 12/2019 - 04/2007
14	Insulin-Like Growth Factor Binding ProteinsIBA 12/2019 - 07/2002
13	LeptinIBA 01/2023 - 03/2010
12	C-PeptideIBA 01/2022 - 02/2004
12	IGF Type 1 Receptor (IGF 1 Receptor)IBA 12/2018 - 12/2002
12	Insulin ReceptorIBA 12/2018 - 12/2007
10	Insulin-Like Growth Factor II (Somatomedin A)IBA 12/2019 - 04/2004
9	AndrogensIBA 10/2023 - 09/2007
9	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 04/2008
9	Phosphotransferases (Kinase)IBA 01/2019 - 01/2004
9	BiguanidesIBA 12/2018 - 09/2010
9	AdiponectinIBA 01/2017 - 11/2008
8	Antineoplastic Agents (Antineoplastics)IBA 11/2022 - 12/2002
8	Carrier Proteins (Binding Protein)IBA 01/2022 - 02/2004
8	beta Carotene (Betacarotene)FDA Link 01/2017 - 11/2002
7	ORALIT (ORS)IBA 01/2022 - 02/2004
7	Insulin-Like Growth Factor Binding Protein 2IBA 01/2019 - 11/2005
6	Prostate-Specific Antigen (Semenogelase)IBA 01/2019 - 07/2002
6	C-Reactive ProteinIBA 04/2017 - 04/2007
6	alpha-Tocopherol FDA Link 01/2017 - 07/2003
6	SteroidsIBA 05/2012 - 08/2008
5	Interleukin-6 (Interleukin 6)IBA 01/2017 - 04/2008
5	AdipokinesIBA 01/2016 - 12/2011
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2013 - 05/2005
5	AntibodiesIBA 02/2012 - 08/2008
4	Estrogens (Estrogen)FDA Link 01/2023 - 02/2013
4	Aromatase (CYP19)IBA 03/2021 - 01/2017
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2018 - 01/2005
4	Vitamin D FDA LinkGeneric 04/2017 - 07/2005
4	Tamoxifen FDA LinkGeneric 01/2016 - 03/2004
4	Insulin-Like Growth Factor Binding Protein 1IBA 01/2016 - 04/2008
4	Testosterone (Sustanon)FDA Link 05/2012 - 09/2011
4	BMS 536924IBA 01/2012 - 12/2008
4	Growth Hormone (Somatotropin)IBA 04/2011 - 07/2002
4	Blood Glucose (Blood Sugar)IBA 11/2010 - 11/2006
4	CarbohydratesIBA 07/2010 - 12/2007
4	Celecoxib (Celebrex)FDA Link 11/2006 - 12/2002
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2020 - 04/2004
3	Serine (L-Serine)FDA Link 12/2018 - 08/2012
3	Tyrosine (L-Tyrosine)FDA Link 10/2018 - 01/2004
3	Messenger RNA (mRNA)IBA 08/2017 - 09/2007
3	EnzymesIBA 04/2017 - 04/2004
3	Somatomedin Receptors (Somatomedin Receptor)IBA 02/2012 - 10/2008
3	Tyrosine Kinase InhibitorsIBA 01/2012 - 08/2008
3	Growth InhibitorsIBA 11/2006 - 04/2004
3	Trastuzumab (Herceptin)FDA Link 11/2006 - 12/2002
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2016
2	Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA 01/2022 - 01/2019
2	Phenformin (Fenformin)IBA 01/2021 - 11/2011
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021 - 03/2016
2	Protein Isoforms (Isoforms)IBA 01/2021 - 03/2009
2	Mechanistic Target of Rapamycin Complex 1IBA 12/2018 - 08/2017
2	Insulin Glargine (Lantus)FDA Link 11/2017 - 01/2014
2	Eukaryotic Initiation Factor-4EIBA 08/2017 - 08/2010
2	TOR Serine-Threonine KinasesIBA 08/2017 - 11/2007
2	Triglycerides (Triacylglycerol)IBA 04/2017 - 01/2016
2	Octreotide (Sandostatin)FDA LinkGeneric 01/2016 - 09/2011
2	ResistinIBA 08/2014 - 01/2013

Therapy/Procedure

27	Therapeutics 10/2023 - 03/2002
8	Drug Therapy (Chemotherapy) 09/2014 - 01/2005
6	Mastectomy (Mammectomy) 12/2023 - 01/2016
6	Castration 01/2019 - 11/2010
2	Chemoprevention 02/2016 - 09/2010
2	Prostatectomy (Retropubic Prostatectomy) 12/2013 - 06/2010